Tuesday, April 28, 2015   

China to put Glaxo investigators on trial
(07-29 16:28)

A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens.
The Shanghai No. 1 Intermediate People's Court said Tuesday that Yingzeng Yu and her husband Peter Humphrey will have a "public trial.'' Authorities had told U.S. and British diplomats they would be barred because the trial involved secret information but later reversed that decision.
Yu and Humphrey were detained last year and accused of improperly obtaining information such as home addresses of Chinese citizens for reports sold to corporate clients.
Yu and Humphrey worked for Glaxo, which faces an investigation into allegations it bribed doctors to use its medicines. Authorities have given no indication whether the two cases are connected. --AP   
Other China breaking news:
9,636 investigated for graft (04-27 16:10)
Industrial profits remain weak (04-27 13:14)
ASEAN says China damages trust, undermines peace (04-27 12:17)
Taiwan Nationalists reach out to Beijing (04-24 16:14)
Woman who murdered abusive husband spared death (04-24 16:10)
Monthly China auto survey launched (04-24 13:12)
New CCTV head appointed (04-24 12:12)
Urban jobless rate slips slightly (04-24 11:54)
Last post for revealing last rites (04-23 20:09)
Beijing becomes Jakarta’s ally in building projects (04-23 17:11)

More breaking news >>

© 2015 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2015, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.